Drug Discovery & Pharmaceuticals

RSS

New compound takes positive step toward creating drug for melanoma

While past attempts to treat melanoma failed to meet expectations, an international team of researchers are hopeful that a compound they tested on both mice and on human cells in a petri dish takes a positive step toward creating a drug that can kill melanoma cancer cells without harming nearby healthy cells.

26 Jul 2017

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

A study published in the New England Journal of Medicine on 20th July 2017 suggests that a cocktail of drugs, if provided at the beginning of the HIV therapy, can save over 10,000 lives per year. HIV, which is often diagnosed late, leaves people vulnerable to other diseases by ravaging the immune system.

25 Jul 2017

UNC receives $5.6 million from NIH to test therapeutic HIV vaccine

A multidisciplinary research team at the University of North Carolina at Chapel Hill has been awarded more than $5.6 million from the National Institutes of Health to test a therapeutic vaccine in people living with HIV.

24 Jul 2017

Likarda uses INTEGRA’s VIAFLO ASSIST to automate cell-based assay development

INTEGRA has published a new video that demonstrates how US-based biotech contract research specialists Likarda LLC are using their VIAFLO ASSIST to cost effectively develop high throughput cell based assays for their customers.

From INTEGRA Biosciences 24 Jul 2017

Cow immunization may lead to new human vaccines and treatments for HIV, study finds

Antibodies against the Human Immunodeficiency Virus (HIV) have been obtained for the first time by injecting cows with an HIV antigen. This achievement offers promise for the development of anti-HIV treatments or vaccines.

21 Jul 2017

Wastewater may become key ally in the fight against antibiotic-resistant microorganisms

Municipal wastewater may become a key ally in the fight against antibiotic-resistant disease-causing bacteria and fungi, a new study at Stellenbosch University found.

20 Jul 2017

Methicillin use not to blame for MRSA, say researchers

The introduction of methicillin into clinical practice is not what caused the emergence of methicillin resistant Staphylococcus aureus (MRSA), report researchers. According to a collaborative study by the University of St Andrews, University of Dundee and the Wellcome Trust Sanger Institute, MRSA existed long before clinicians started using the antibiotic.

20 Jul 2017

Avantor opens new state-of-the-art Innovation Center in Bridgewater, New Jersey

Avantor, a global supplier of ultra-high-purity materials for customers across the life sciences and advanced technologies sectors, has opened a new research center in Bridgewater, New Jersey (USA) to help biopharmaceutical and pharmaceutical customers with a full range of upstream and downstream processes, from gene to protein expression through final formulation and drug delivery.

20 Jul 2017

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

A boosting skin vaccination with a biodegradable microneedle patch and protein constructed from sequences of influenza virus subtypes could improve the effectiveness of conventional influenza vaccines, according to a study led by Georgia State University.

19 Jul 2017

Developing software for cell and gene therapy supply chain tracking

The first thing is, to always remember that we're dealing with a living drug, cells, which are very sensitive to environmental conditions, such as temperature and humidity etc. All of those things can impact on the viability of the drug and its effectiveness.

18 Jul 2017

New bioanalytical method could pave way for personalized drug therapy

Personalized drug therapy, adjusting the dose, dosage intervals, and the duration of treatment to fit individual patients' needs, are getting more and more important.

17 Jul 2017

NIH researchers show how investigational drug works against rare, fatal genetic disease

Scientists have demonstrated how an investigational drug works against a rare, fatal genetic disease, Niemann-Pick type C1 (NPC1).

17 Jul 2017

Mayo Clinic and nference launch startup to develop drugs for rare diseases

Today, Mayo Clinic and nference launch a startup company for drug development that will be powered by clinical expertise and artificial intelligence (AI).

14 Jul 2017

Pharma, biotech and healthcare industries gender gap

The pharma and biotech industry continues to struggle to make progress with gender diversity. A recent Credit Suisse report shows that management diversity, as defined by percentage of women in senior management roles, has decreased globally from 18.9 percent in 2014 to 15.5 percent in 2016.

13 Jul 2017

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

The treatment of osteosarcoma, the most common tumor of bone, is challenging. A study led by The University of Texas MD Anderson Cancer Center found a drug known as bone metastasis-targeting peptidomimetic (BMTP-11) has potential as a new therapeutic strategy for this devastating illness.

13 Jul 2017

Salford scientists may have found simple way for designing new antibiotics

CANCER researchers in the UK may have stumbled across a solution to reverse antibiotic drug resistance and stop infections like MRSA.

12 Jul 2017

E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease

E-Scape Bio announced an extension of its Series A funding to a total of $63 million. Created as a spin-off from research conducted at the Gladstone Institutes, E-Scape Bio is a biopharmaceutical company with a mission to develop new therapies to treat neurodegenerative disorders such as Alzheimer's disease.

12 Jul 2017

Computational analysis of open-access data points to new ways of using drugs

A research team led by scientists at UC San Francisco has developed a computational method to systematically probe massive amounts of open-access data to discover new ways to use drugs, including some that have already been approved for other uses.

12 Jul 2017

Erectile dysfunction drug may be used to coat stents in future heart surgeries

Coating stents with an erectile dysfunction drug may be the way forwards in treating stent patients, say researchers.

12 Jul 2017

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

ERYTECH Pharma, a French clinical-stage biopharmaceutical company developing innovative therapies for rare forms of cancer and orphan diseases, today announced that it has entered into a research collaboration with Queen's University in Canada to advance the preclinical development of ERYTECH's eryminase program specifically for the treatment of arginase-1 deficiency, a rare and severe metabolic disorder related to arginine metabolism.

12 Jul 2017

Drug Discovery & Pharmaceuticals

New compound takes positive step toward creating drug for melanoma

Cocktail of drugs for HIV patients with advanced immunosuppression reduced deaths by 27%, study shows

UNC receives $5.6 million from NIH to test therapeutic HIV vaccine

Likarda uses INTEGRA’s VIAFLO ASSIST to automate cell-based assay development

Cow immunization may lead to new human vaccines and treatments for HIV, study finds

Wastewater may become key ally in the fight against antibiotic-resistant microorganisms

Methicillin use not to blame for MRSA, say researchers

Avantor opens new state-of-the-art Innovation Center in Bridgewater, New Jersey

Skin-applied microneedle patch boosts immunization to seasonal flu vaccine recipients, study finds

Developing software for cell and gene therapy supply chain tracking

New bioanalytical method could pave way for personalized drug therapy

NIH researchers show how investigational drug works against rare, fatal genetic disease

Mayo Clinic and nference launch startup to develop drugs for rare diseases

Pharma, biotech and healthcare industries gender gap

Bone metastasis-targeting drug shows potential as new therapeutic strategy for osteosarcoma

Salford scientists may have found simple way for designing new antibiotics

E-Scape Bio announces extension of funding to develop novel drug for Alzheimer's disease

Computational analysis of open-access data points to new ways of using drugs

Erectile dysfunction drug may be used to coat stents in future heart surgeries

ERYTECH partners with Queen’s University to advance its product candidate for treating arginase-1 deficiency

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Latest Life Science News